Current:Home > Contact-usFDA approves gene-editing treatment for sickle cell disease-LoTradeCoin
FDA approves gene-editing treatment for sickle cell disease
View Date:2024-12-23 23:17:39
The U.S. Food and Drug Administration on Friday approved a landmark gene-editing treatment for sickle cell disease, a painful condition that affects approximately 100,000 people in the United States, predominantly people of color. The innovative therapy promises to repair the gene responsible for the disease.
The breakthrough offers a beacon of hope for Johnny Lubin, a 15-year-old from Connecticut who has lived with the debilitating effects of the disease. He inherited the sickle cell gene from both of his parents and has experienced severe pain and health complications since infancy.
Red blood cells, which are normally donut-shaped, bend into inflexible sickle shapes, causing them to pile up inside blood vessels and prevent the normal delivery of oxygen in the body. Complications include bone deterioration, strokes and organ failure.
Doctors told Lubin he would not live past 40.
"I was starting to get a little bit scared. Like I actually did want to live past 40," he said.
For more than a decade, Lubin was in and out of the hospital. He said he would count how many times he had been in each hospital room and at one point he realized he had been in every room on the floor.
Johnny's parents, Fabienne and J.R. Lubin, were desperate for a solution when they learned about a cutting-edge clinical trial involving gene editing, a process not requiring a donor.
First, stem cells were removed from Lubin's bone marrow and he was given chemotherapy to help wipe out the abnormal cells.
Then, in a laboratory, the editing technology called CRISPR was used to increase the amount of a protective form of hemoglobin, a protein that picks up oxygen from lungs and delivers it throughout the body — that protective form usually diminishes after birth. The cells were then infused back into Lubin's bloodstream.
Dr. Monica Bhatia, who is Johnny's doctor and the chief of pediatric stem cell transplantation at NewYork-Presbyterian/Columbia University Irving Medical Center, said by editing the cell, you're reprogramming cells to produce fetal hemoglobin.
"It's been widely known that fetal hemoglobin is somewhat protective and those who have higher levels of fetal hemoglobin tend to have less severe symptoms of sickle cell disease," she said.
"You're changing somebody's DNA. So obviously you wanna make sure that the corrections you're making are, are the ones you want," said Bhatia.
After a challenging five weeks in the hospital and a six-month absence from school, Lubin has drastically improved health and prospects for a longer life.
"I thought that was pretty cool how I have like new cells and I honestly hoped, you know, I could get, you know, some super powers from it, you know, maybe become a superhero, you know, like genetically engineered," Lubin said.
The treatment, called Casgevy, was developed by the Boston-based Vertex Pharmaceuticals and CRISPR Therapeutics.
Patients will have to be followed long-term before the experts call this a cure. Gene editing is expected to cost several million dollars per patient and may not be appropriate for everyone who has sickle cell disease. It would also not prevent the gene from being passed down to future generations.
Jon LaPookDr. Jonathan LaPook is the chief medical correspondent for CBS News.
TwitterveryGood! (7)
Related
- Kevin Costner Shares His Honest Reaction to John Dutton's Controversial Fate on Yellowstone
- Alabama man shot by police during domestic violence call
- Spider-Man's Marisa Tomei Shares Sweet Part of Zendaya and Tom Holland Romance
- Ex-jailer in Mississippi is charged in escape of inmate who had standoff with Chicago police
- DWTS' Gleb Savchenko Shares Why He Ended Brooks Nader Romance Through Text Message
- Maine workers make progress in cleanup of spilled firefighting foam at former Navy base
- Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Turn Up the Heat
- You practice good hygiene. So why do you still smell bad?
- Tech consultant testifies that ‘bad joke’ led to deadly clash with Cash App founder Bob Lee
- These Secrets About Mary Poppins Are Sweeter Than a Spoonful of Sugar
Ranking
- Atlanta man dies in shootout after police chase that also kills police dog
- Eminem's daughter cried listening to his latest songs: 'I didn't realize how bad things were'
- Receiver CeeDee Lamb agrees to 4-year, $136M deal with Cowboys, AP sources say
- Old Navy Shoppers Rave That This Denim Jacket Looks More Expensive Than It Is & It’s on Sale for $30
- Republican Dan Newhouse wins reelection to US House in Washington
- Special counsel urges appeals court to reinstate classified documents case against Trump
- Travis Kelce and Jason Kelce Score Eye-Popping Podcast Deal Worth at Least $100 Million
- US appeals court revives a lawsuit against TikTok over 10-year-old’s ‘blackout challenge’ death
Recommendation
-
This is Your Sign To Share this Luxury Gift Guide With Your Partner *Hint* *Hint
-
Clemson football coach Dabo Swinney won't take live calls on weekly radio show
-
Second Romanian gymnast continuing to fight for bronze medal in Olympic floor final
-
Need a table after moving? Pizza Hut offering free 'moving box table' in select cities
-
US Congress hopes to 'pull back the curtain' on UFOs in latest hearing: How to watch
-
Army private who fled to North Korea will plead guilty to desertion
-
Christina Hall Lasers Off Tattoo on Wedding Ring Finger Amid Josh Hall Divorce
-
Watch as curious black bear paws at California teen's leg in close encounter